QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates

American Heart Journal

Volumn 133, Issue 1, 1997, Pages 108-111

  Stramba Badiale, M ^a   Nador, F ^a   Porta, N ^a   Guffanti, S ^a   Frediani, M ^a   Colnaghi, C ^a   Grancini, F ^a   Motta, G ^a   Carnelli, V ^a   Schwartz, P J ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRAMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL TOXOPLASMOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QT INTERVAL; RESUSCITATION; TORSADE DES POINTES;

EID: 0030999832     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70255-2     Document Type: Article

References (19)

1. LM Hondeghem DJ Snyders Class III antiarrhythmic agents have a lot of potential but a long way to go Circulation 82 1990 2235 2242
2. SG Priori L Diehl PJ. Schwartz Torsade de pointes PJ Podrid PR Kowey Cardiac arrhythmia. Mechanisms, diagnosis, and management 1995 Williams & Wilkins Baltimore, Md 951 963
3. BP Monahan CL Ferguson ES Killeavy BK Lloyd J Troy LR Catilena Torsades des pointes occurring in association with terfenadine use JAMA 264 1990 2788 2790
4. CM Pratt RP Hertz BE Ellis SP Crowell W Louv Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine Am J Cardiol 73 1994 346 352
5. R Nattel S Ranger M Talajic R Lemery D Roy Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism Am J Med 89 1990 235 238
6. M Stramba-Badiale S Guffanti N Porta M Frediani G Beria C Colnaghi QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant Am Heart J 126 1993 740 742
7. PD Higham SS Furniss RWF Campbell QT dispersion and components of the QT interval in ischemia and infarction Br Heart J 73 1995 32 36
8. SG Priori C Napolitano L Diehl PJ Schwartz Dispersion of QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome Circulation 89 1994 1681 1689
9. F Nador G Beria GM De Ferrari M Stramba-Badiale EH Locati A Lotto Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic and pathogenic implications Circulation 84 1991 1530 1542
10. RR Makkar BS Fromm RT Steinman MD Meissner MH Lehmann Female gender as a risk factor for torsades des pointes associated with cardiovascular drugs JAMA 270 1993 2590 2597
11. M Stramba-Badiale D Spagnolo G Bosi PJ Schwartz Are genderdifferences in QTc present at birth? Am J Cardiol 75 1995 1277 1278
12. PM Rautaharju SH Zhou S Wong HP Calhoun GS Berenson R Prineas Sex differences in the evolution of the electrocardiographic QT interval with age Can J Cardiol 8 1992 690 695
13. CM Hunt PB Watkins P Saenger GM Stave N Barlascini CO Watlington Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol Clin Pharmacol Ther 51 1992 18 23
14. M Rubart ML Pressler HP Pride DP Zipes Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome [abstract] Circulation 88 1993 1832 1844
15. ZQ Zhang C. Antzelevitch Erythromycin produces prominent action potential prolongation and early afterdepolarization (EAD)–induced triggered activity in M but not epicardial or endocardial regions of the canine ventricle Circulation 88 1993 I-327
16. P Daleau E Lessard MF Groleau J Turgeon Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes Circulation 91 1995 3010 3016
17. kr potassium channel Cell 81 1995 299 307
18. C Jiang D Atkinson JA Towbin I Splawski MH Lehmann H Li Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity Nat Genet 8 1994 141 147
19. J Wei M Wathen K Murray R Daw D Roden AL Veorge Jr Absence of HERG and SCN5A mutations in acquired long QT syndrome [abstract] Circulation 92 1995 I-275